#Pharma #Healthcare #GLP1 #ObesityCare #Innovation #Teva #NovoNordisk To view or add a comment, sign in BREAKING NEWS Pfizer bets $7.3B on obesity contender Metsera after internal pipeline setbacks Pfizer has just announced a definitive agreement to acquire Metsera, a clinical-stage company focused on obesity treatments
Abrahamsson, N., Engstrom, B
Official Verification: Enhance.MD is a legitimate telehealth provider operating in the United States
Both forms serve the same purpose in the body and are synthesized from the same amino acids
However, taking the drug may pose other health risks for older adults that arent yet well understood because of the small number of participants over age 65 in the Ozempic clinical trials
Overall, psyllium is a promising functional ingredient with potential applications in health and industry, and more comprehensive research will facilitate its optimal use